Onderneming Aurinia Pharmaceuticals Inc. Toronto S.E.
Aandelen
CA05156V1022
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutic Drugs
100,0
%
| 134 | 100,0 % | 176 | 100,0 % | +30,95% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
90,0
%
| 102 | 76,4 % | 158 | 90,0 % | +54,17% |
Japan
10,0
%
| 31 | 23,5 % | 18 | 10,0 % | -44,24% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Martin
FOU | Founder | 52 | 16-06-93 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 29-04-19 |
Robert Foster
FOU | Founder | 65 | 16-06-93 |
Joseph Miller
DFI | Director of Finance/CFO | 50 | 27-04-20 |
Compliance Officer | 42 | 01-01-14 | |
Matthew Donley
COO | Chief Operating Officer | 55 | 18-07-19 |
Sue Evans
LAW | General Counsel | - | 01-01-14 |
Fran Lynch
SAM | Sales & Marketing | - | 25-02-20 |
Scott Habig
PRN | Corporate Officer/Principal | 64 | 15-07-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Foster
FOU | Founder | 65 | 16-06-93 |
R. MacKay-Dunn
BRD | Director/Board Member | 73 | 26-06-19 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 29-04-19 |
Jill Leversage
BRD | Director/Board Member | 67 | 13-11-19 |
Jeffrey Bailey
BRD | Director/Board Member | 62 | 18-08-23 |
Michael Martin
FOU | Founder | 52 | 16-06-93 |
Karen Smith
BRD | Director/Board Member | 56 | 18-08-23 |
David Jaynee
BRD | Director/Board Member | 67 | 26-05-15 |
Director/Board Member | 44 | 14-06-21 | |
Daniel Billen
CHM | Chairman | 70 | 29-04-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 143 019 365 | 132 907 345 ( 92,93 %) | 0 | 92,93 % |
Bedrijfsgegevens
Aurinia Pharmaceuticals, Inc.
14315 – 118 Avenue Suite 140
T5L 4S6, Edmonton
+250 744 2487
http://www.auriniapharma.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,17% | 127 mld. | |
+24,67% | 117 mld. | |
+25,44% | 27,67 mld. | |
-17,74% | 20,33 mld. | |
-15,17% | 16,79 mld. | |
-15,21% | 15,63 mld. | |
+11,91% | 14,84 mld. | |
-47,10% | 14,65 mld. | |
+54,50% | 14,43 mld. |